Alexis Renta
Interventional Pain Medicine · Boynton Beach, FLNPI 1407870736
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $271 and has fallen 66.9% since, to $90 in 2023. That places this record below the midpoint for interventional pain medicine clinicians in FL, where the typical reported total is $4,625.
Across 32 payments — averaging $29.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$205
- Nevro Corp.$200
- Galderma Laboratories, L.p.$196
- Medtronic$90
- Pfizer$68
- Teva Pharmaceuticals USA, Inc.$59
- plus $132 from 6 others
Across 94 payments — averaging $11,957 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$579K
- AstraZeneca$545K
What the payments were for
- Travel & lodging$172%
- Food & beverage$93498%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 12 | $205 |
| Nevro Corp. | 3 | $200 |
| Galderma Laboratories, L.p. | 2 | $196 |
| Medtronic | 1 | $90 |
| Pfizer | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Indivior Inc. | 2 | $44 |
| Titan Pharmaceuticals, Inc. | 2 | $26 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Fidia Pharma USA Inc. | 1 | $13 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$120
How this compares
$951 in reported general payments places this provider in the 20th percentile of 278 interventional pain medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SavellaMilnacipran Hcl | 12 | $5,888 |
| Xtampza ErOxycodone Myristate | 12 | $4,708 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 22 | $3,846 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 140 | $2,803 |
| Pregabalin | 154 | $1,945 |
| Duloxetine Hcl | 69 | $1,530 |
| Lidocaine | 17 | $1,362 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $1,223 |
| Oxycodone Hcl | 58 | $648 |
| Gabapentin | 49 | $452 |
| Paroxetine Hcl | 13 | $367 |
| Diclofenac Sodium | 16 | $264 |
| Celecoxib | 13 | $181 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 18 | $136 |
| Tizanidine Hcl | 40 | $124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSavella | $13 | $5,88812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Boynton Beach
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.